Related Experiment Videos
Neurotoxicity with single dose intrathecal midazolam administration
B Ugur1, K Basaloglu, T Yurtseven
1Adnan Menderes University Medical Faculty, Department of Anaesthesiology and Reanimation, Aydin, Turkey. bakiyeugur@hotmail.com
European Journal of Anaesthesiology
|December 2, 2005
Summary
Intrathecal midazolam administration in rabbits caused neurotoxic effects on spinal cord neurons and myelinated axons. These electron microscopic changes, including myelin separation and nuclear irregularities, were observed 24 hours and 6 days post-administration.
Area of Science:
- Neuroscience
- Toxicology
- Electron Microscopy
Background:
- Investigating the effects of intrathecal midazolam on the spinal cord is crucial for understanding potential neurological risks.
- Midazolam is commonly used for anesthesia and sedation, but its long-term effects via intrathecal administration require detailed examination.
Purpose of the Study:
- To examine the electron microscopic alterations in the spinal cord medulla following intrathecal midazolam administration.
- To assess the neurotoxic potential of midazolam when delivered directly into the cerebrospinal fluid.
Main Methods:
- Twenty-eight rabbits were divided into two groups: one receiving intrathecal midazolam (300 microg) and a control group receiving normal saline.
- Spinal cord samples were collected 24 hours and 6 days post-administration for electron microscopic examination.
- Microscopic analysis focused on changes in neurons and myelinated axons within the medulla.
Main Results:
- Midazolam-treated rabbits exhibited severe myelin lamella separation in large axons and a honeycomb appearance.
- Degenerate vacuoles in the cytoplasm and nuclear membrane irregularities were noted in neurons of midazolam-treated groups.
- Control groups showed regular myelin lamella and nuclear membranes, with some vacuoles and edema observed in neurons.
Conclusions:
- Single-dose intrathecal midazolam administration may induce neurotoxic effects on spinal cord neurons and myelinated axons.
- These neurotoxic effects are evident at both 24 hours and 6 days after administration.
- The findings highlight the potential risks associated with intrathecal midazolam use.